Searches , social queries for MITOTANE
Search references for MITOTANE. Phrases containing MITOTANE
See searches and references containing MITOTANE!
Search references for MITOTANE. Phrases containing MITOTANE
See searches and references containing MITOTANE!MITOTANE
Chemical compound
Mitotane, sold under the brand name Lysodren, is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of
Mitotane
Cancer of the adrenal cortex
mitotane in addition to surgery when compared to surgery alone. The two most common regimens are cisplatin, doxorubicin, etoposide (EDP) + mitotane,
Adrenocortical_carcinoma
Medical condition
hormones. Mitotane was historically the only treatment used for pituitary dependent Cushing's in dogs and is relatively cheap. Disadvantages of mitotane as a
Cushing's syndrome (veterinary)
Cushing's_syndrome_(veterinary)
Tumors of the adrenal gland
without reoccurrence, Mitotane has also been used in the non-surgical management of adrenocortical carcinomas as adjuvant therapy. Mitotane is given orally
Adrenal_tumor
Chemical compound
is switched to ortho-position, the result is the chemotherapeutic agent mitotane. This is an example of a positional isomer. The following are synonyms
Dichlorodiphenyldichloroethane
Dichlorodiphenyldichloroethane
and adrenal steroidogenesis inhibitors like ketoconazole, metyrapone, mitotane, and aminoglutethimide, have corticotropic or procorticotropic effects
Anticorticotropin
Genetic disease of dogs resulting in hair loss
to treat alopecia X, such as: growth hormones, castration, melatonin, mitotane, and trilostane. Treatment is not always effective, and because hair cycle
Alopecia_X
Autoimmune disease
proteins. Estrogen, tamoxifen, heroin, methadone, clofibrate, 5-fluorouracil, mitotane, and perphenazine all increase thyroid binding globulin (TBG) concentration
Hashimoto's_thyroiditis
Medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Tretinoin
Corticosteroid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Dexamethasone
Antiprogestogen and antiglucocorticoid drug
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Mifepristone
Medication and naturally occurring steroid hormone
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Progesterone_(medication)
Sex hormone
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Progesterone
Class of steroid hormones
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Corticosteroid
Medical condition
as prednisone to decrease symptoms associated with adrenal withdrawal. Mitotane is also used A study of 3,525 cases of TSS for Cushing's disease in the
Cushing's_disease
Chemotherapy and immunosuppressant medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Methotrexate
Industrial chemical and medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Arsenic_trioxide
Glucocorticoid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Fluticasone_propionate
Steroidal antiandrogen and antimineralocorticoid
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Spironolactone
Steroid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Mometasone
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Navitoclax
Glucocorticoid and mineralocorticoid hormone Cortisol supplied as a medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Hydrocortisone
Chemical compound and pharmaceutical drug
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Cisplatin
Steroid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Prednisone
Medication used as chemotherapy and to suppress the immune system
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Cyclophosphamide
Antifungal chemical compound
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Ketoconazole
Cancer drug
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Protein-bound_paclitaxel
Medication used to treat cancer
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Carboplatin
American pharmaceutical company
Erbitux (cetuximab) Etopophos (etoposide) Ixempra (ixabepilone) Lysodren (mitotane) Megace (megestrol acetate) Opdivo (nivolumab) is a programmed death receptor
Bristol_Myers_Squibb
Pharmaceutical preparation
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical trials:
Tobramycin/dexamethasone
Pharmaceutical drug classification
Masoprocol L01XX11 Estramustine L01XX16 Mitoguazone L01XX18 Tiazofurine L01XX23 Mitotane L01XX24 Pegaspargase L01XX27 Arsenic trioxide L01XX29 Denileukin diftitox
ATC_code_L01
Corticosteroid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Prednisolone
Glucocorticoid steroid (chemical compound)
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Betamethasone_dipropionate
Chemical compound
levels. Analogues of metyrapone include aminoglutethimide, amphenone B, and mitotane. Metyrapone has been found in early human trials to reduce recollection
Metyrapone
no tests with both high sensitivity and specificity. Treatments include mitotane, trilostane, ketoconazole, or selegiline. Surgery is used in some cases
List_of_dog_diseases
Chemical compound (cancer therapy drug)
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Olaparib
Chemotherapy medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Doxorubicin
Chemical compound
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Fluticasone
Inhalable drug
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Beclometasone/formoterol
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Chlormethine
Chemical compound
Cushing's. The only previous treatment for the disease was the use of mitotane (brand name Lysodren) off-label. A number of compounding pharmacies in
Trilostane
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Pharmacodynamics of progesterone
Pharmacodynamics_of_progesterone
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Hazardous_drug
Group of corticosteroids
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Mineralocorticoid
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Gemcitabine
U.S. health institute
Hydroxyurea (Hydrea) (1967) Procarbazine (Matulane) (1969) O, P'-DDD (Lysodren, Mitotane) (1970) Dacarbazine (DTIC) (1975) CCNU (Lomustine) (1976) BCNU (Carmustine)
National_Cancer_Institute
Medication for skin
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical trials:
Topical_steroid
Drug class
(P450scc, CYP11A1) inhibitors such as aminoglutethimide, ketoconazole, and mitotane inhibit the production of pregnenolone from cholesterol and thereby prevent
Steroidogenesis_inhibitor
Mineralocorticoid steroid hormone
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Aldosterone
Chemical compound
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Finerenone
Gene therapy medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Lisocabtagene_maraleucel
Chemotherapy medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Fluorouracil
Pharmaceutical drug
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Eribulin
Chemical compound (chemotherapy medication)
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Cytarabine
Chemical compound
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Eplerenone
Steroid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Triamcinolone
Corticosteroid precursor and metabolite of cortisol
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Cortisone
Medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Venetoclax
Nonsteroidal anti-inflammatory medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Celecoxib
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Vatalanib
Reddening, swelling, numbness and skin peeling due to chemotherapy
(1974). "Erythematous eruption of the palms and soles associated with mitotane therapy". Dermatologica. 148 (2): 90–2. doi:10.1159/000251603. PMID 4276191
Chemotherapy-induced acral erythema
Chemotherapy-induced_acral_erythema
Pharmaceutical drug
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Vinorelbine
Drug
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Proteasome_inhibitor
Chemotherapy medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Docetaxel
Pharmaceutical drug
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Tebentafusp
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Eganelisib
Biochemical Molecule
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical trials:
Hydroxycorticosteroids
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
List_of_antineoplastic_agents
Tumor of the pituitary gland
steroidogenesis inhibitors (ketoconazole, metyrapone, osilodrostat, etomidate or mitotane) which decrease production of cortisol, pituitary blockers such as somatostatin
Pituitary_adenoma
Medication for the treatment of conditions where certain blood cells are dysfunctional,
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Decitabine
Endogenous non-proteinogenic amino acid
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Aminolevulinic_acid
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Nirogacestat
Steroid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Betamethasone
Glycopeptide antibiotic used to treat various cancers
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Bleomycin
Chemical compound
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Hydrocortisone_aceponate
Chemotherapy medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Etoposide
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Dactinomycin
Pharmaceutical drugs
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Alkylating antineoplastic agent
Alkylating_antineoplastic_agent
Cancer medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Temozolomide
Medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Clobetasol_propionate
Cell based gene therapy
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Brexucabtagene_autoleucel
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Sotorasib
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Pharmacokinetics of progesterone
Pharmacokinetics_of_progesterone
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
MOPP_(chemotherapy)
Pharmaceutical drug
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Cladribine
Nuclear receptor that mediates the effects of the mineralocorticoid hormone Aldosterone
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Mineralocorticoid_receptor
Type of corticosteroid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Budesonide
Artificial stimulation of the immune system to treat cancer
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Cancer_immunotherapy
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Atrasentan
Chemotherapeutic agents used to treat cancer
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Platinum-based_antineoplastic
Family of chemical compounds
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Nitrogen_mustard
Medication drug
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Drospirenone
Pharmaceutical medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Calaspargase_pegol
Gene therapy medication used to treat multiple myeloma
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Ciltacabtagene_autoleucel
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Capecitabine
Chemotherapy medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Vinblastine
Medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Loteprednol/tobramycin
Medication
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Vusolimogene_oderparepvec
Chemical compound
Idroxioleic acid Imetelstat Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Navitoclax Nirogacestat Oblimersen† Omacetaxine mepesuccinate Para-toluenesulfonamide
Taxane
Corticosteroid medication
Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never
Methylprednisolone
travel, tourism, insurance
MITOTANE
MITOTANE
MITOTANE
MITOTANE
MITOTANE
MITOTANE
MITOTANE
MITOTANE
MITOTANE
travel, tourism, insurance